Mark Rothera's Net Worth
Mark Rothera's net worth is estimated to be at least $7,067,273.06 as of 05/05/2024. CoreStreet's estimation of Mark Rothera's net worth is based on their sale of stock and current holding of stock.
Mark Rothera is CEO at Viracta Therapeutics Inc. They have executed at least 12 trades of stock as per SEC Form 4 filings. Their most recent trade was for 52,094 units of VIRX stock on 11/30/2023. Their biggest sale was on 02/25/2015 when they sold 35,000 units of PTC Therapeutics Inc stock for $2,380,350.00. They typically trade 2 times per year.
Total value of insider buys:
- $412,986.06
Total value of insider sells:
- $6,654,287.00
Most recent insider trade:
- Nov. 30, 2023
Mark Rothera's Insider Trading History
| Viracta Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 30, 2023 | CEO | 52,094 | $0.49 | Buy | $25,526.06 |
| PTC Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 3, 2016 | Insider | 2,000 | $6.23 | Buy | $12,460.00 |
March 17, 2015 | Insider | 10,700 | $76.64 | Sell | $820,048.00 |
Feb. 25, 2015 | Insider | 35,000 | $68.01 | Sell | $2,380,350.00 |
Feb. 24, 2015 | Insider | 1,000 | $67.70 | Sell | $67,700.00 |
Feb. 23, 2015 | Insider | 23,000 | $65.40 | Sell | $1,504,200.00 |
Jan. 20, 2015 | Insider | 3,000 | $60.02 | Sell | $180,060.00 |
Jan. 16, 2015 | Insider | 2,300 | $58.67 | Sell | $134,941.00 |
Jan. 14, 2015 | Insider | 9,700 | $58.04 | Sell | $562,988.00 |
Sept. 26, 2014 | Insider | 16,000 | $44.63 | Sell | $714,080.00 |
Sept. 15, 2014 | Insider | 8,000 | $36.24 | Sell | $289,920.00 |
June 25, 2013 | Insider | 25,000 | $15.00 | Buy | $375,000.00 |